Myofunctional therapy (MT) nozzle for Snoring

Phase-Based Progress Estimates
Mayo Clinic in Arizona, Scottsdale, AZ
Snoring+2 More
Myofunctional therapy (MT) nozzle - Device
All Sexes
What conditions do you have?

Study Summary

This research study is being done to determine whether the repetition and resistance from the daily use of the myofunctional therapy (MT) nozzle will improve obstructive sleep apnea and primary snoring.

Eligible Conditions

  • Snoring
  • Obstructive Sleep Apnea (OSA)

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: 60 days

60 days
Adherence to
Baseline, 60 days
Change in quality of life

Trial Safety

Trial Design

2 Treatment Groups

Myofunctional therapy (MT) nozzle
1 of 2
Placebo nozzle
1 of 2
Experimental Treatment
Non-Treatment Group

40 Total Participants · 2 Treatment Groups

Primary Treatment: Myofunctional therapy (MT) nozzle · Has Placebo Group · N/A

Myofunctional therapy (MT) nozzle
Experimental Group · 1 Intervention: Myofunctional therapy (MT) nozzle · Intervention Types: Device
Placebo nozzle
PlaceboComparator Group · 1 Intervention: Placebo nozzle · Intervention Types: Other

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 60 days
Closest Location: Mayo Clinic in Arizona · Scottsdale, AZ
Photo of Scottsdale 1Photo of Scottsdale 2Photo of Scottsdale 3
2011First Recorded Clinical Trial
1 TrialsResearching Snoring
225 CompletedClinical Trials

Who is running the clinical trial?

National Institutes of Health (NIH)NIH
2,390 Previous Clinical Trials
24,521,517 Total Patients Enrolled
1 Trials studying Snoring
31 Patients Enrolled for Snoring
Mayo ClinicLead Sponsor
2,860 Previous Clinical Trials
3,686,121 Total Patients Enrolled
Umesh Goswami, MBBS, MDPrincipal InvestigatorMayo Clinic

Eligibility Criteria

Age 18+ · All Participants · 1 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.